The aim of this study was to compare and evaluate the clinical and cost-effectiveness of transurethral vaporisation of the prostate (TUVP), a new electrosurgical modality, with the standard treatment, transurethral resection of the prostate (TURP) to treat bladder outflow obstruction in men with benign prostatic hyperplasia.